Upcoming Events

September 28-29, 2011: 3rd Annual Outsourcing in Clinical Trials New England

Presentation Details: Representatives from Cato BioVentures will attend the 3rd Annual Outsourcing in Clinical Trials New England in Boston, Massachusetts.

The Outsourcing in Clinical Trials series primarily serves to give rise to new, successful business relationships. As the industry is under increasing pressure to make clinical trials more efficient while keeping costs under control, creating solid partnerships and developing effective outsourcing strategies are pivotal to beating competition and key to successful and continuous drug development.

For more information and to register: Outsourcing in Clinical Trials New England

October 12, 2011: NCBIO Annual Meeting

Presentation Details: Representatives from Cato BioVentures will attend the 2011 NCBIO Annual Meeting in Research Triangle Park, North Carolina.

Dr. Andrew von Eschenbach, former Commissioner of the Food and Drug Administration will be a Keynote Speaker at the NCBIO Annual Meeting at the North Carolina Biotechnology Center. Dr. von Eschenbach will discuss medical innovation policy and offer unique insights stemming from his years of experience at the FDA, the National Cancer Institute and the American Cancer Society.

For more information and to register: NCBIO

October 19, 2011 – 5-8PM: Cato Research and Cato BioVentures Host Wine Tasting and Reception

Details: Cato Research and Cato BioVentures will be hosting a Wine Tasting and Reception at the Cato Research Washington office in Rockville, Maryland on October 19, 2011 from 5-8 PM. Please join us for an array of delicious appetizers, as well as wines from Dr. Cato's personal collection. We look forward to seeing you there!

To register: Wine Tasting and Reception Registration

Directions: Cato Research Washington Office

October 25-26, 2011: 10th Annual BIO Investor Forum

Presentation Details: Representatives from Cato BioVentures will attend the 10th Annual BIO Investor Forum in San Francisco, California.

The 10th Annual BIO Investor Forum is an international investor conference focused on private and emerging public biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

For more information and to register: BIO Investor Forum